We speculated that a single injection of CXCR3-CD8+ T cells was sufficient to reduce tumor growth in our 4T1-mouse model, whereas the addition of anti-PD1 was necessary to induce the efficacy of CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.